https://www.selleckchem.com/pr....oducts/wortmannin.ht
© Georg Thieme Verlag KG Stuttgart · New York.Background The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC] plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 inhibitor) in patients with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) is unclear. Purpose To examine the effects of dual versus triple therapy on bleeding and ischemic outcomes in adults with AF after PCI. Data Sources Searches of PubMed, EMBASE, and the Cochrane Library
Like
Comment
Share
